IQVIA Holdings Inc (IQV)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE
Market Cap: $43.69B
Last updated: Nov 17, 2026 at 11:06 AM ET
IQVIA Holdings Inc (IQV) Earnings: Report Dates and Results
IQVIA Holdings (IQV) is expected to report earnings on Feb 3, 2027. In the quarter ended Sep 30, 2026, IQVIA Holdings reported EPS of $2.95, above the $2.94 estimate. It beat the EPS estimate in each of the last 39 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
IQV has an expected report date of Feb 3, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 5.8% above the $3.42 reported for the quarter ended Dec 31, 2025.
IQV Earnings Call
The latest IQV earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, IQV beat 39 and missed 1. Revenue for the quarter ended Sep 30, 2026 was $4.43B, up 8.0% from $4.10B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $2.95 | $2.94 | N/A | +0.34% | Beat | -1.7% | 17 | 2 up, 0 down | Oct 27, 2026 | $4.43B |
| Jun 30, 2026 | $2.75 | $2.72 | N/A | +1.10% | Beat | -2.1% | 18 | 0 up, 2 down | Jul 28, 2026 | $4.37B |
| Mar 31, 2026 | $2.90 | $2.82 | $2.71 - $2.88 | +2.84% | Beat | +7.4% | 19 | 0 up, 3 down | May 5, 2026 | $4.15B |
| Dec 31, 2025 | $3.42 | $3.40 | $3.34 - $3.43 | +0.59% | Beat | +9.6% | 19 | 1 up, 0 down | Feb 5, 2026 | $4.36B |
| Sep 30, 2025 | $3.00 | $2.98 | $2.92 - $3.05 | +0.67% | Beat | +5.6% | 19 | 2 up, 1 down | Oct 28, 2025 | $4.10B |
| Jun 30, 2025 | $2.81 | $2.77 | $2.73 - $2.83 | +1.44% | Beat | +6.4% | 17 | 0 up, 2 down | Jul 22, 2025 | $4.02B |
| Mar 31, 2025 | $2.70 | $2.63 | $2.60 - $2.68 | +2.66% | Beat | +6.3% | 19 | 1 up, 5 down | May 6, 2025 | $3.83B |
| Dec 31, 2024 | $3.12 | $3.11 | $3.04 - $3.16 | +0.32% | Beat | +9.9% | 20 | 1 up, 0 down | Feb 6, 2025 | $3.96B |
| Sep 30, 2024 | $2.84 | $2.81 | $2.75 - $2.91 | +1.07% | Beat | +14.1% | 20 | 3 up, 1 down | Oct 31, 2024 | $3.90B |
| Jun 30, 2024 | $2.64 | $2.56 | $2.43 - $2.62 | +3.13% | Beat | +8.6% | 20 | 1 up, 2 down | Jul 22, 2024 | $3.81B |
| Mar 31, 2024 | $2.54 | $2.48 | $2.41 - $2.53 | +2.42% | Beat | +3.7% | 19 | 1 up, 0 down | May 2, 2024 | $3.74B |
| Dec 31, 2023 | $2.84 | $2.82 | $2.80 - $2.85 | +0.71% | Beat | +2.2% | 18 | 1 up, 0 down | Feb 14, 2024 | $3.87B |
| Sep 30, 2023 | $2.49 | $2.45 | $2.35 - $2.49 | +1.63% | Beat | +0.4% | 18 | 4 up, 1 down | Nov 1, 2023 | $3.74B |
| Jun 30, 2023 | $2.43 | $2.37 | $2.30 - $2.44 | +2.53% | Beat | -0.4% | 20 | 1 up, 1 down | Aug 1, 2023 | $3.73B |
| Mar 31, 2023 | $2.45 | $2.41 | N/A | +1.66% | Beat | -0.8% | 20 | 0 up, 0 down | Apr 27, 2023 | $3.65B |
| Dec 31, 2022 | $2.78 | $2.76 | $2.71 - $2.80 | +0.72% | Beat | +9.0% | 19 | 1 up, 1 down | Feb 10, 2023 | $3.74B |
| Sep 30, 2022 | $2.48 | $2.38 | $2.30 - $2.42 | +4.20% | Beat | +14.3% | 16 | 1 up, 0 down | Oct 26, 2022 | $3.56B |
| Jun 30, 2022 | $2.44 | $2.38 | N/A | +2.52% | Beat | +14.6% | N/A | 1 up, 0 down | Jul 21, 2022 | $3.54B |
| Mar 31, 2022 | $2.47 | $2.42 | $2.36 - $2.46 | +2.07% | Beat | +13.3% | 17 | 1 up, 1 down | Apr 27, 2022 | $3.57B |
| Dec 31, 2021 | $2.55 | $2.43 | $2.40 - $2.48 | +4.94% | Beat | +20.9% | 18 | N/A | Feb 15, 2022 | $3.64B |
| Sep 30, 2021 | $2.17 | $2.12 | $2.09 - $2.27 | +2.36% | Beat | +33.1% | 19 | 0 up, 0 down | Oct 21, 2021 | $3.39B |
| Jun 30, 2021 | $2.13 | $2.08 | $2.02 - $2.17 | +2.40% | Beat | +80.5% | 18 | N/A | Jul 27, 2021 | $3.44B |
| Mar 31, 2021 | $2.18 | $1.86 | $1.82 - $1.90 | +17.20% | Beat | +45.3% | 18 | N/A | Apr 22, 2021 | $3.41B |
| Dec 31, 2020 | $2.11 | $2.00 | $1.97 - $2.04 | +5.50% | Beat | +21.3% | 20 | N/A | Feb 10, 2021 | $3.30B |
| Sep 30, 2020 | $1.63 | $1.54 | $1.23 - $1.58 | +5.84% | Beat | +1.9% | 20 | N/A | Oct 20, 2020 | $2.79B |
| Jun 30, 2020 | $1.18 | $1.06 | $1.03 - $1.14 | +11.32% | Beat | -22.9% | 21 | N/A | Jul 22, 2020 | $2.52B |
| Mar 31, 2020 | $1.50 | $1.48 | $1.46 - $1.52 | +1.35% | Beat | -2.0% | 17 | N/A | Apr 28, 2020 | $2.75B |
| Dec 31, 2019 | $1.74 | $1.72 | $1.68 - $1.76 | +1.16% | Beat | +16.0% | 18 | N/A | Feb 12, 2020 | $2.90B |
| Sep 30, 2019 | $1.60 | $1.57 | $1.55 - $1.60 | +1.91% | Beat | +12.7% | 17 | N/A | Oct 30, 2019 | $2.77B |
| Jun 30, 2019 | $1.53 | $1.49 | $1.47 - $1.52 | +2.68% | Beat | +18.6% | 18 | N/A | Jul 24, 2019 | $2.74B |
| Mar 31, 2019 | $1.53 | $1.51 | $1.46 - $1.54 | +1.32% | Beat | +14.2% | 18 | N/A | May 1, 2019 | $2.68B |
| Dec 31, 2018 | $1.50 | $1.47 | $1.45 - $1.51 | +2.04% | Beat | +7.1% | 20 | N/A | Feb 14, 2019 | $2.69B |
| Sep 30, 2018 | $1.42 | $1.39 | $1.37 - $1.44 | +2.16% | Beat | +19.3% | 20 | N/A | Oct 22, 2018 | $2.59B |
| Jun 30, 2018 | $1.29 | $1.23 | $1.21 - $1.26 | +4.88% | Beat | +18.3% | 18 | N/A | Jul 24, 2018 | $2.57B |
| Mar 31, 2018 | $1.34 | $1.27 | $1.24 - $1.32 | +5.51% | Beat | +32.7% | 16 | N/A | May 2, 2018 | $2.56B |
| Dec 31, 2017 | $1.40 | $1.34 | $1.31 - $1.38 | +4.48% | Beat | +204.3% | 19 | N/A | Feb 14, 2018 | $2.52B |
| Sep 30, 2017 | $1.19 | $1.14 | N/A | +4.39% | Beat | +19.0% | N/A | N/A | Oct 26, 2017 | $2.47B |
| Jun 30, 2017 | $1.09 | $1.05 | N/A | +3.81% | Beat | +17.2% | N/A | N/A | Aug 3, 2017 | $2.35B |
| Mar 31, 2017 | $1.01 | $0.96 | N/A | +5.21% | Beat | +13.5% | N/A | N/A | May 3, 2017 | $2.36B |
| Dec 31, 2016 | $0.46 | $1.05 | N/A | -56.19% | Miss | -48.9% | N/A | N/A | Feb 14, 2017 | $2.27B |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $11.93, up 7.1% from the year before. It was $3.28 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $11.93 | +7.1% |
| Dec 31, 2024 | $11.14 | +9.1% |
| Dec 31, 2023 | $10.21 | N/A |
| Dec 31, 2022 | $10.17 | +12.6% |
| Dec 31, 2021 | $9.03 | +40.7% |
| Dec 31, 2020 | $6.42 | N/A |
| Dec 31, 2019 | $6.40 | +15.3% |
| Dec 31, 2018 | $5.55 | +18.3% |
| Dec 31, 2017 | $4.69 | +43.0% |
| Dec 31, 2016 | $3.28 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 6,700 words across 11 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 6,739 | 11 | |
| 2026Q2 | Jun 30, 2026 | 5,993 | 13 | |
| 2026Q1 | Mar 31, 2026 | 5,430 | 10 | |
| 2025Q4 | Dec 31, 2025 | 5,405 | 10 | |
| 2025Q3 | Sep 30, 2025 | 5,710 | 12 | |
| 2025Q2 | Jun 30, 2025 | 6,098 | 14 | |
| 2025Q1 | Mar 31, 2025 | 6,061 | 10 | |
| 2024Q4 | Dec 31, 2024 | 5,172 | 11 |
2026Q3 Earnings Call
Opening remarks
Kerri Joseph Senior Vice President, Investor Relations Thank you all. Good morning, everyone. Thank you for joining our third quarter 2026 earnings call. With me today are Ari Bousbib, Chairman and Chief Executive Officer; Michael J. Fedock, Executive Vice President and Chief Financial Officer; Eric Sherbet, Executive Vice President and General Counsel; Clarissa Willett, Senior Vice President of Financial Planning and Analysis; and Katie Ward, Vice President, Investor Relations. Today, we will be referencing a presentation that will be visible during this call to those of you on our webcast. This presentation will also be available following this call in the Events and Presentations section of our IQVIA Investor Relations website at ir.iqvia.com. Before we begin, I would like to caution listeners that certain information discussed by management during this conference call will include forward-looking statements. Actual results could differ materially from those stated or implied by forward-looking statements due to risks and uncertainties associated with the company's business, which are discussed in the company's filings with the Securities and Exchange Commission, including our annual report on Form 10-K and subsequent SEC filings. In addition, we will discuss certain non-GAAP financial measures on this call, which should be considered a supplement to, and not a substitute for, financial measures prepared in accordance with GAAP. A reconciliation of these non-GAAP measures to comparable GAAP measures is included in the press release and conference call presentation. As previously disclosed, we implemented a new reporting structure that is effective January 1, 2026. In conjunction with this change, prior-period amounts have been recast to conform to this reporting structure. I would now like to turn the call over to our Chairman and CEO, Ari Bousbib.
Ari Bousbib Chairman and Chief Executive Officer Thank you, Kerri, and good morning, everyone. Thank you for joining us today to discuss our third quarter results. The team delivered great numbers. The market environment has continued to improve, but our performance improved even more. Our organic growth rates year over year accelerated meaningfully: two times for commercial and nearly three times for clinical. Our margins expanded, and free cash flow was very strong. Our win rates were higher in the quarter, which led to our strongest clinical bookings in four years. Our differentiated AI offerings are increasingly contributing to that momentum, with continued adoption of our agentic solutions. In fact, IQVIA has now deployed 415 agents to date. Earlier this month, we brought together more than 400 attendees at Tech IQ to share our latest clinical and commercial AI capabilities. This event is our annual customer event focused on technology, which this year took place in Boston and included our technology partners NVIDIA, Microsoft, AWS, Snowflake, and Veeva.
Frequently Asked Questions About IQV
When is IQVIA Holdings's next earnings date?
IQVIA Holdings's next earnings report is expected for Feb 3, 2027.
Did IQV beat earnings estimates last quarter?
Yes. IQVIA Holdings reported EPS of $2.95 for the quarter ended Sep 30, 2026, above the $2.94 estimate, a 0.34% surprise.
What EPS do analysts expect from IQV next quarter?
The consensus EPS estimate for IQVIA Holdings for the quarter ending Dec 31, 2026 is $3.62 from 19 analysts, with estimates from $3.48 to $3.80.
How often does IQV beat earnings estimates?
IQVIA Holdings beat the EPS estimate in each of the last 39 quarters, with an average surprise of +3.16%.
IQV pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors